流脑防治的微生态学的实验研究

本文初探人咽部正常菌群对Ａ群、Ｂ群脑膜炎奈瑟氏菌生长的影响。结果显示,调查人群中２４１７％的人咽部存在可抑制Ａ群脑膜炎奈瑟氏菌生长的细菌;一般健康者、流脑病人密切接触者和流脑病人之间差异不显著。对４１株抑制Ａ群脑膜炎奈瑟氏菌生长的细菌的检测可见,有２３株（占５６１０％）对Ｂ群脑膜炎奈瑟氏菌生长有抑制作用;有５株菌对８种实验标准致病菌的生长都有抑制作用,表明人咽部正常菌群对致病菌拮抗作用的非特异性和多重性。部分人咽部正常菌群细菌的代谢产物亦可抑制Ａ、Ｂ群脑膜炎奈瑟氏菌生长     

肺炎患者与健康人口咽部菌群分析

目的观察肺炎患者口咽部菌群分布情况,探讨肺炎患者与健康人群口咽部菌群分布差异。方法采集细菌性肺炎稳定期患者(29例)和健康人群(31例)咽拭子进行细菌培养,并对其咽部菌落进行计数和菌种鉴定。结果肺炎患者咽拭子培养中主要致病菌和条件致病菌检出种类和检出率较健康者明显增加,肺炎组与健康组相比需氧菌与厌氧菌的菌群密度具有上升趋势,使用t检验计算结果差异有统计学意义(P0.05)。在可培养的肺炎组人群口咽菌群中肺炎链球菌检出率最高,其次为微球菌、副溶血链球菌、甲型链球菌;在健康体检人群口咽部菌群中甲型链球菌检出率最高,其次为奇异变形杆菌、微杆菌属、轻型链球菌、颗粒链球菌。结论与健康对照组相比,肺炎患者口咽部菌群分布紊乱,且肺炎组患者呼吸道菌群数量明显增多。     

哮喘患儿口咽部菌群分析及3株优势菌的拮抗作用

了解哮喘患儿呼吸道菌群多样性及其组成特征, 同时研究所分离的3株优势菌对流感嗜血杆菌的抑制作用, 探究哮喘与呼吸道菌群之间的关系。

采集沈阳市儿童医院呼吸内科2019年3月至2019年12月收治的21例4~12岁急性发作期哮喘患儿咽拭标本, 并同时采集23例同龄健康儿童的咽拭标本作为对照, 对呼吸道菌群进行分离培养、纯化和16S rRNA鉴定。采用牛津杯法检测健康儿童口咽部分离的3株优势菌对流感嗜血杆菌的拮抗作用。

哮喘和健康儿童呼吸道培养出的需氧菌(t=2.143, P=0.038)和厌氧菌(t=3.270, P=0.002)的密度差异有统计学意义。哮喘患儿咽部需氧菌以肺炎链球菌和流感嗜血杆菌为主, 厌氧菌以韦荣球菌为主。健康儿童咽部需氧菌以缓症链球菌和口腔链球菌为主, 厌氧菌以干酪乳杆菌为主。健康儿童口咽部的3株优势菌对哮喘儿童口咽部流感嗜血杆菌的生长具有显著抑制作用。

与健康儿童相比, 哮喘患儿口咽部菌群发生紊乱, 且哮喘患儿口咽部需氧菌、厌氧菌密度显著增加。健康儿童口咽部的某些优势菌可能对哮喘致病菌的定植有一定的拮抗作用。

     

2007年重庆市流脑流行季节前健康人群抗体水平和带菌率调查

为了解重庆市流脑流行季节前健康人群免疫水平和带菌状况,预测发病趋势,提出新的免疫策略,提供有效的预防措施。按照全国流脑监测方案并结合重庆市2006年流脑疫情情况,选择重庆市北碚区、长寿区和万盛区为2007年流脑监测点,采集0~、5~、10~、15~、25~、35~及45岁以上共7个年龄组人群的静脉血和咽拭子,分别进行抗体水平和带菌率检测。结果显示,重庆市健康人群A群流脑IgG抗体的阳性率为76.02%(485/638),C群流脑IgG抗体的阳性率为47.65%(304/638),健康人群脑膜炎奈瑟菌(简称Nm)带菌率为0.47%(3/638)。重庆市健康人群A群流脑IgG抗体阳性率维持在较高水平,而C群流脑IgG抗体的阳性率较低,提示该市大部分人群对A群流脑有免疫作用,但C群抗体水平较低,有引起局部流脑爆发的风险。     

健康人群中脑膜炎奈瑟氏菌菌群分布变迁的调查

流行性脑膜炎奈瑟氏菌(简称流脑菌)在健康人群中菌群分布变迁情况的了解,对预测流脑流行情况有重要意义。为了掌握本地区流脑健康人群带菌菌群分布,于1976—1978年进行了菌群调查。现将情况汇报如下。     

天然药物蜂房化学成分提取物对口腔细菌生长的实验研究

目的研究蜂房中分离得到的不同组分对致龋菌生长的影响,寻找蜂房抑龋的有效成分。方法通过溶剂分段和层析技术对蜂房进行分离,得到4个组分,采用液体稀释法研究蜂房不同组分对口腔常居细菌——血液链球菌、唾液链球菌,以及4种主要致龋菌——变形链球菌、内氏放线菌、粘性放线菌和乳酸杆菌生长的影响,使用活菌计数法测量五倍子总鞣质及各组分对变形链球菌生长曲线的影响。结果蜂房提取物中1、2和3组分对实验菌有较强的抑菌作用,蜂房提取物3组分对于变形链球菌生长曲线的抑制作用最强。结论蜂房各组分对实验菌都有一定的抑菌作用,其抑菌作用可能和其中的甾醇类化合物有关。     

2019年河南省健康人群流行性脑脊髓膜炎A群、C群抗体水平监测

目的了解2019年河南省健康人群流行性脑脊髓膜炎(epidemic cerebrospinal meningitis,简称流脑)A群、C群抗体水平状况,为科学制定防控策略提供依据。方法采用分层随机抽样的方法采集健康人群血清,用间接ELISA检测流脑A群、C群抗体浓度。结果共检测1 689份健康人群血清标本,其中流脑A群抗体阳性率为54.23%,抗体质量浓度中位数为2.18μg/mL;流脑C群抗体阳性率为51.51%,抗体质量浓度中位数为2.07μg/mL。不同地区之间流脑A群、C群抗体水平的差异、阳性率的差异均有统计学意义(P<0.05)。不同年龄组之间流脑A群、C群抗体水平的差异、阳性率的差异均有统计学意义(P<0.05)。结论河南省健康人群流脑A群、C群抗体水平和阳性率都比较低,有发生流脑暴发和流行的血清学基础,应加强流脑监测和预防接种的管理工作。     

新生儿咽部微群落研究

本文调查了一周龄新生长的口咽部菌群,结果显示有约５０％的５－７天龄的新生儿其咽部正常的甲型链球菌群未能建立,易于为致病性较强的菌株定植,这段时间是这部份新生儿的敏感“窗期”。表皮葡萄球菌也是在新生儿口咽部最早定值的“先驱菌”之一,但对新生儿似无保护作用,其致病作用表现得亦不明显。     

1例流行性脑脊髓膜炎病例的菌群鉴定及分析

目的对2015年河南省1例流行性脑脊髓膜炎(流脑)病例的菌群进行分子分型鉴定及分析,为河南省流脑预防和控制工作提供科学依据。方法对患者脑脊液和血液标本以及37例密切接触者咽拭子标本进行细菌培养,提取DNA进行PCR及多位点序列分型(multilocus sequence typing,MLST)分析。用ELISA检测密切接触者血清标本的脑膜炎奈瑟菌A群和C群抗体水平。结果患者和1例密切接触者分离的菌株经细菌培养及PCR鉴定,分别为C群和B群脑膜炎奈瑟菌。MLST分型显示,患者和密切接触者标本分别为ST4821型和ST5664型,两者均为ST4821克隆群。37例密切接触者脑膜炎奈瑟菌A群和C群抗体阳性率分别为91.89%和21.62%,平均抗体质量浓度分别为6.50μg/m L和1.73μg/m L。结论引起流脑疫情的致病菌为C群ST4821型脑膜炎奈瑟菌,当地C群平均抗体含量偏低,需加强流脑A+C疫苗的接种,有效预防流脑的暴发。     

口炎清及其组分体外抑菌作用

目的考察口炎清及其组分对肠道部分优势菌群和条件致病菌以及口腔血链球菌和变链球菌生长的影响。方法以选择性培养基培养为基础的活菌计数法。结果 5%和10%的口炎清及其组分对葡萄球菌、大肠埃希菌均有明显的抑制作用。5%和10%的口炎清及其组分对植物来源乳酸杆菌和人来源乳酸杆菌生长抑制效果不明显,只有10%山银花流膏有一定抑制效果。10%的山银花流膏、口炎清、玄参流膏对血链球菌和变链球菌有较明显的抑制作用。5%和10%的天冬麦冬流膏对双歧杆菌的生长有促进作用。结论口炎清及其组分对于葡萄球菌、大肠埃希菌、血链球菌、变链球菌有明显的抑制作用,而对乳酸杆菌抑制作用不明显,其中某些成分还有促进双歧杆菌生长作用。     

Whole-genome sequence of the transformable Neisseria meningitidis serogroup A strain WUE2594

Serogroup A meningococci are a leading cause of bacterial meningitis in children and young adults worldwide. However, the genetic basis of serogroup A strains' virulence and their epidemiological properties remain poorly understood. Therefore, we sequenced the complete genome of the transformable Neisseria meningitidis serogroup A strain WUE2594.     

Epidemiological evaluation of Neisseria meningitidis serogroup B by pulsed-field gel electrophoresis

Abstract Genomic DNA from 25 strains of serogroup B Neisseria meningitidis was subjected to pulsed-field gel electrophoresis (PFGE) after digestion with Spe I. N. meningitidis genomic DNA displayed considerable diversity. The diversity we observed among these strains was stable and included isolates from an outbreak that were phenotypically identical. This confirms the value of macrorestriction profiling and PFGE in providing epidemiologically stable strain markers for typing meningococci.     

Immunogenicity and evolutionary variability of epitopes within IgA1 protease from serogroup A Neisseria meningitidis

Five murine epitopes were defined and mapped within IgA1 protease produced by Neisseria meningitidis. Epitopes 1 and 2 were present in IgA1 protease from all strains, and from Neisseria gonorrhoeae. Epitopes 3 through to 5 varied between subgroups of serogroup A meningococci. but have remained constant over decades within the subgroups, except for epitope 4, which changed between 1983 and 1987 during the spread of subgroup III meningococci from Asia to Africa. Binding of monoclonal antibodies to epitopes 1, 4 and 5 neutralized enzymatic function. Human sera containing antibodies to lgA1 protease as a result of natural infection inhibited binding of monoclonal antibodies to epitope 4 but not to the other epitopes.     

HmbR outer membrane receptors of pathogenic Neisseria spp.: iron-regulated, hemoglobin-binding proteins with a high level of primary structure conservation.

We have recently cloned and characterized the hemoglobin receptor gene from Neisseria meningitidis serogroup C. N. meningitidis cells expressing HmbR protein were able to bind biotinylated hemoglobin, and the binding was specifically inhibited by unlabeled hemoglobin and not heme. The HmbR-mediated hemoglobin binding activity of N. meningitidis cells was shown to be iron regulated. The presence of hemoglobin but not heme in the growth medium stimulated HmbR-mediated hemoglobin binding activity. The efficiency of utilization of different hemoglobins by the HmbR-expressing N. meningitidis cells was shown to be species specific; human hemoglobin was the best source of iron, followed by horse, rat, turkey, dog, mouse, and sheep hemoglobins, The phenotypic characterization of HmbR mutants of some clinical strains of N. meningitidis suggested the existence of two unrelated hemoglobin receptors. The HmbR-unrelated hemoglobin receptor was shown to be identical to Hpu, the hemoglobin-haptoglobin receptor of N. meningitidis. The Hpu-dependent hemoglobin utilization system was not able to distinguish between different sources of hemoglobin; all animal hemoglobins were utilized equally well. HmbR-like genes are also present in N. meningitidis serogroups A and B, Neisseria gonorrhoeae MS11 and FA19, Neisseria perflava, and Neisseria polysaccharea. The hemoglobin receptor genes from N. meningitidis serogroups A and B and N. gonorrhoeae MS11 were cloned, and their nucleotide sequences were determined. The nucleotide sequence identity ranged between 86.5% (for N. meningitidis serogroup B hmbR and MS11 hmbR) and 93.4% (for N. meningitidis serogroup B hmbR and N. meningitidis serogroup C hmbR). The deduced amino acid sequences of these neisserial hemoglobin receptors were also highly related, with overall 84.7% conserved amino acid residues. A stop codon was found in the hmbR gene of N. gonorrhoeae MS11. This strain was still able to use hemoglobin and hemoglobin-haptoglobin complexes as iron sources, indicating that some gonococci may express only the HmbR-independent hemoglobin utilization system.     

Genetic subgroups of Neisseria meningitidis serogroup A isolated from patients with disseminated forms of meningococcal infection in Moscow, 1969-2006

Results of microbiological monitoring for serogroup A Neisseria meningitidis circulated in Moscow from 2002 to 2006 are presented. Using multilocus sequence-typing, molecular and epidemiologic characteristics of 32 cultures isolated from cerebro-spinal fluid of patients with generalized forms of meningococcal infection. Typed isolates belonged to 4 sequence types: CT-3349 (detected in 24 cultures), CT-2 (detected in 5 cultures), CT-75 (detected in 2 cultures), and CT-5803 (detected in 1 culture). All sequence types (except CT-5803) were detected in Moscow in previous years. Using Internet database (http://pubmlst.org/neisseria) they were genetically characterized and compared with data on serogroup A meningococci circulated in Moscow before 2002., meningococci belonging to epidemically dangerous genetic subgroup III were not detected between characterized strains. Typed isolates were distributed between subgroups VI and X, which are typical for the area under surveillance. Genetic changes in Moscow population of Neisseria meningitidis serogroup A, which manifested by shift of dominating genetic subgroup after 2002-2003, were analyzed.     

Characterization of serogroup C meningococci isolated from 14 provinces of China during 1966-2005 using comparative genomic hybridization

Neisseria meningitidis is a major cause of bacterial meningitis and septicemia worldwide. In China, serogroup A strains were responsible for over 95% of the cases, while serogroup B strains were mainly the cause of localized outbreaks and sporadic cases. Before 2003, serogroup C strains were only recovered from a few sporadic cases. However, a sudden increase in the number of cases due to serogroup C strains occurred during 2003-2005 in Anhui Province, China. Many cases were found in other provinces at the same time. Multilocus sequence typing (MLST) results indicated that the unique sequence type 4821 clone meningococci, a new hyper-virulent lineage, was responsible for the serogroup C meningitis outbreaks. We have completed the project of sequencing the whole genome of the Chinese N. meningitidis serogroup C representative isolate 053442. We fabricated a whole-genome microarray of N. meningitidis isolate 053442 and analyzed the genome composition differences among 81 serogroup C isolates which were isolated from 14 provinces of China during 1966-2005. The comparative genomic hybridization (CGH) result shows that the genome compositions of nearly all serogroup C isolates are similar to that of 053442. The products of many absent open reading frames (ORFs) are conserved hypothetical proteins. The results will provide a valuable resource from which one can analyze the genome composition and genetic background of serogroup C meningococci in China.     

Measurement of opsonophagocytic activity of antibodies specific toNeisseria meningitidis serogroup A capsular polysaccharide-serogroup B outer membrane vesicle conjugate in animal model

Neisseria meningitidis is efficiently phagocytosed by polymorphonuclear leukocytes (PMNS) following opsonization with opsonic antibodies; opsonophagocytosis is the primary mechanism for clearance of meningococci from the host. Thus, in testing meningococcal vaccines, the level of opsonophagocytic antibodies appears to correlate with vaccine-induced protection. Our previous studies demonstrated that the conjugation ofN. meningitidis serogroup A capsular polysaccharide (CPSA) to serogroup B outer membrane vesicle (OMV) could induce a high level of bactericidal antibody response against serogroup A meningococci in animals. The purpose of this study was to evaluate opsonophagocytic activity of the conjugate of CPSA to OMV (CPSA-OMV). In order to evaluate the potential efficacy of CPSA-OMV a flow cytometric opsonophagocytic assay was used. The conjugate and controls were injected intramuscularly into four groups of rabbits with boosters on days 14, 28 and 42 following primary immunization. The rabbits were bled prior to injection and two weeks after each injection. Opsonophagocytic activity of antibodies in hyperimmune sera through rabbit PMNS were measured with flow cytometer, using dihydrorhodamine-123 as a probe. The results indicated that our conjugate could induce a highly significant level of opsonophagocytic activity against serogroup A meningococci after 56 days compared to the control groups (P<0.05). We conclude that this conjugate represents a vaccine candidate against serogroups A and B meningococci after further investigation.     

A modified ex vivo human whole blood model of infection for studying the pathogenesis of Neisseria meningitidis during septicemia

For the purpose of establishing a model to study host-bacteria interaction and virulence mechanisms of Neisseria meningitidis during the septic phase of disease a modified human whole blood model of infection is proposed. Compared to published whole blood models the current model was modified with respect to the initial number of viable bacteria (10(4) cfu ml(-1)), the anticoagulant used and the incubation time. The results obtained after incubation of a number of human blood samples from healthy volunteers for 24 h with serogroup B meningococci were in good agreement with findings reported from patients who suffered severe meningococcal disease.     

Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001

With the recent introduction of polysaccharide-protein conjugated vaccines for the control of serogroup C meningococcal disease and the emergence of different variants of serogroup C meningococci, it is likely the epidemiology of meningococcal disease in many countries may be affected. We have therefore analysed and reported the characteristics of Neisseria meningitidis strains collected in 2001 from the Canadian surveillance program on invasive meningococcal disease. Only strains collected from normally sterile clinical sites of patients were studied. Of the 289 isolates obtained from individual patients, 173 (59.9%) were serogroup C, 76 (26.3%) were serogroup B, 30 (10.4%) were serogroup Y, and 10 (3.5%) were serogroup W135. Ninety-six percent of the serogroup C isolates belonged to the ET-15 clone, with an additional 2.3% belonging to other electrophoretic types within the ET-37 clonal complex. Different antigenic variants of the endemic serogroup C ET-15 clone were responsible for localized outbreaks in different parts of the country. One novel variant with the antigenic composition of C:2a:P1.1,7 was reported in two provinces, Quebec and Ontario. Eighteen percent of the meningococci isolated from patients in Ontario belonged to serogroup Y, compared with only 8% in the rest of Canada. The current data highlight the importance of strain characterization by serogroup, serotype, and serosubtype antigens in providing useful information for the surveillance of meningococcal disease in Canada.     

The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase

Neisseria meningitidis serogroup A capsular polysaccharide (CPS) is composed of a homopolymer of O-acetylated, alpha1-->6-linked ManNAc 1-phosphate that is distinct from the capsule structures of the other meningococcal disease-causing serogroups, B, C, Y, and W-135. The serogroup A capsule biosynthetic genetic cassette consists of four open reading frames, mynA-D (sacA-D), that are specific to serogroup A, but the functions of these genes have not been well characterized. mynC was found to encode an inner membrane-associated acetyltransferase that is responsible for the O-acetylation of the CPS of serogroup A. The wild-type CPS as revealed by 1H NMR had 60-70% O-acetylated ManNAc residues that contained acetyl groups at O-3, with some species acetylated at O-4 and at both O-3 and O-4. A non-polar mynC mutant generated by introducing an aphA-3 kanamycin resistance cassette produced CPS with no O-acetylation. A serogroup A capsule-specific monoclonal antibody was shown to recognize the wild-type O-acetylated CPS, but not the CPS of the mynC mutant, which lacked O-acetylation. MynC was C-terminally His-tagged and overexpressed in Escherichia coli to obtain the predicted approximately 26-kDa protein. The acetyltransferase activity of purified MynC was demonstrated in vitro using [14C]acetyl-CoA. MynC O-acetylated the O-acetylated CPS of the mynC mutant and further acetylated the wild-type CPS of serogroup A meningococci, but not the CPS of serogroup B or C meningococci. Genetic complementation of the mynC mutant confirmed the function of MynC as the serogroup A CPS O-3 and O-4 acetyltransferase. MynC represents a new subclass of O-acetyltransferases that utilize acetyl-CoA to decorate the D-mannosamine capsule of N. meningitidis serogroup A.